SLAMF7 (CD319/CS1) is expressed in plasmablastic lymphoma and is a potential diagnostic marker and therapeutic target
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15393
Abstract: The plasmablastic lymphomas (PBLs) are a group of aggressive B cell neoplasms that share pathobiological features with large B cell lymphoma (LBCL) and plasma cell myeloma. They are characterized by a diffuse proliferation of large… read more here.
Keywords: lymphoma; plasmablastic lymphoma; cd319 cs1; slamf7 cd319 ... See more keywords